TCI Revolutionizes Weight Management with Breakthrough GLP-1 Innovation

September 11, 2024 05:56 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

TAIPEI, Sept. 11, 2024 /PRNewswire/ -- TCI Co. Ltd. ("TCI", 8436.TWO), a global leader in ODM health and cosmetic products for over 40 years, introduces its cutting-edge GLP-1 formula, a natural blend of plant extracts, probiotics, and prebiotics designed to deliver powerful weight management results.

The global obesity crisis continues to surge. In 2022, the WHO reported over one billion people as obese—around one-eighth of the global population. By 2035, the World Obesity Federation predicts the economic cost of obesity will exceed $4 trillion annually. Meanwhile, The Economist projects that the weight loss and obesity drug market will skyrocket to $150 billion by the early 2030s, with GLP-1 analogs becoming as widely used as medications for blood pressure or cholesterol.

The Science Behind TCI's GLP-1 Formula

TCI leverages its proprietary Bio-Resource Data Mining technology, an AI-powered system that autonomously identifies potent natural compounds. Backed by in-vitro studies and human trials, TCI's GLP-1 formula has proven to be a game-changer in the health and wellness sector. The formula stimulates natural GLP-1 secretion, enhances fat metabolism, stabilizes blood glucose, and induces white fat browning—making it an effective solution for sustainable weight management.

Internal human trials confirmed the GLP-1 formula's ability to promote GLP-1 secretion and regulate blood glucose levels. Cell experiments further validated its effectiveness in stimulating natural GLP-1 production from intestinal L-cells, which is key to controlling appetite and promoting fat loss.

"At TCI, we develop high-performance supplements based on scientifically proven data, ensuring our clients' products enhance consumer health and quality of life," said Vincent Lin, Chairman of TCI.

Real Results: TCI Employees Experience GLP-1 Formula Success

TCI invited employees to try the GLP-1 formula, with participants losing an average of 4.9 kg in just two months—fostering enthusiasm for healthier lifestyles. Available in liquid, powder sachets, and tablet forms, the formula is now being fast-tracked for international markets through partnerships with global clients. TCI's mission is to deliver natural, convenient weight management solutions that not only transform consumers' lives but also set new standards for the health and nutrition industry.

What is GLP-1?
GLP-1 (Glucagon-Like Peptide-1) is a hormone primarily secreted by intestinal L-cells in response to food intake. It plays a key role in regulating insulin secretion, suppressing glucagon release, reducing appetite, and slowing gastric emptying—all crucial for controlling hunger and supporting weight loss.

Clinical Benefits of TCI's GLP-1 Formula

Enhanced GLP-1 Secretion
In a controlled trial, participants given the GLP-1 formula showed a significant 10.3% increase in GLP-1 concentration within 60 minutes, compared to those who did not take the formula. This boost helped maintain stable GLP-1 levels, reducing hunger and supporting healthy weight loss.

Stabilized Postprandial Blood Glucose
In another study, participants' blood glucose levels were measured after consuming breakfast with and without the GLP-1 formula. Remarkably, the formula reduced glucose spikes by 97%, demonstrating its powerful ability to stabilize post-meal blood sugar levels.

Proven Weight Management Efficacy
A 4-week human trial showed that daily use of the GLP-1 formula led to notable improvements in key health markers. Participants experienced a 4.2% reduction in total cholesterol, a 2.93% increase in HDL ("good" cholesterol), and a 2.71% decrease in LDL ("bad" cholesterol), lowering the risk of cardiovascular disease while effectively managing weight.

TCI's innovative GLP-1 formula is paving the way for a healthier future by offering natural, science-backed solutions for weight management. As the global demand for effective weight loss solutions grows, TCI remains at the forefront, leading the charge in transforming how consumers approach their health and well-being.

Related link:https://www.tci-bio.com/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.